66 related articles for article (PubMed ID: 20956467)
1. 17beta-estradiol augments 18F-FDG uptake and glycolysis of T47D breast cancer cells via membrane-initiated rapid PI3K-Akt activation.
Ko BH; Paik JY; Jung KH; Lee KH
J Nucl Med; 2010 Nov; 51(11):1740-7. PubMed ID: 20956467
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin stimulates endothelial cell 18F-FDG uptake through focal adhesion kinase-mediated phosphatidylinositol 3-kinase/Akt signaling.
Paik JY; Ko BH; Jung KH; Lee KH
J Nucl Med; 2009 Apr; 50(4):618-24. PubMed ID: 19289426
[TBL] [Abstract][Full Text] [Related]
4. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and hormonal stimulation: is glycolysis the first sign of response?
Linden HM; Mankoff DA
J Nucl Med; 2010 Nov; 51(11):1663-4. PubMed ID: 20956476
[No Abstract] [Full Text] [Related]
6. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
[TBL] [Abstract][Full Text] [Related]
7. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
8. EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.
Jung KH; Lee EJ; Park JW; Lee JH; Moon SH; Cho YS; Lee KH
PLoS One; 2019; 14(9):e0221294. PubMed ID: 31532771
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia stimulates 18F-fluorodeoxyglucose uptake in breast cancer cells via hypoxia inducible factor-1 and AMP-activated protein kinase.
Smith TA; Zanda M; Fleming IN
Nucl Med Biol; 2013 Aug; 40(6):858-64. PubMed ID: 23786679
[TBL] [Abstract][Full Text] [Related]
10. Influence of resistance to 5-fluorouracil and tomudex on [18F]‑FDG incorporation, glucose transport and hexokinase activity.
Law AA; Collie-Duguid ES; Smith TA
Int J Oncol; 2012 Jul; 41(1):378-82. PubMed ID: 22576694
[TBL] [Abstract][Full Text] [Related]
11. 3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition.
Kelly CJ; Hussien K; Muschel RJ
Nucl Med Biol; 2012 Oct; 39(7):986-92. PubMed ID: 22682985
[TBL] [Abstract][Full Text] [Related]
12. Prevention of brown adipose tissue activation in 18F-FDG PET/CT of breast cancer patients receiving neoadjuvant systemic therapy.
Aukema TS; Vogel WV; Hoefnagel CA; Valdés Olmos RA
J Nucl Med Technol; 2010 Mar; 38(1):24-7. PubMed ID: 20159933
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation.
Borowiec AS; Hague F; Harir N; Guénin S; Guerineau F; Gouilleux F; Roudbaraki M; Lassoued K; Ouadid-Ahidouch H
J Cell Physiol; 2007 Sep; 212(3):690-701. PubMed ID: 17520698
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone Stimulates Cancer Cell Uptake of 18F-FDG by Suppressing Mitochondrial Respiration and Augments Sensitivity to Glucose Restriction.
Moon SH; Lee SJ; Jung KH; Quach CH; Park JW; Lee JH; Cho YS; Lee KH
J Nucl Med; 2016 Jan; 57(1):129-35. PubMed ID: 26449833
[TBL] [Abstract][Full Text] [Related]
15. 17β-estradiol activates glucose uptake via GLUT4 translocation and PI3K/Akt signaling pathway in MCF-7 cells.
Garrido P; Morán J; Alonso A; González S; González C
Endocrinology; 2013 Jun; 154(6):1979-89. PubMed ID: 23546602
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor DNA binding is not required for estrogen-induced breast cell growth.
DeNardo DG; Cuba VL; Kim H; Wu K; Lee AV; Brown PH
Mol Cell Endocrinol; 2007 Oct; 277(1-2):13-25. PubMed ID: 17825481
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis.
Kampa M; Nifli AP; Charalampopoulos I; Alexaki VI; Theodoropoulos PA; Stathopoulos EN; Gravanis A; Castanas E
Exp Cell Res; 2005 Jul; 307(1):41-51. PubMed ID: 15922725
[TBL] [Abstract][Full Text] [Related]
18. CNK1 is a novel Akt interaction partner that promotes cell proliferation through the Akt-FoxO signalling axis.
Fritz RD; Varga Z; Radziwill G
Oncogene; 2010 Jun; 29(24):3575-82. PubMed ID: 20383191
[TBL] [Abstract][Full Text] [Related]
19. Activation of rapid signaling pathways and the subsequent transcriptional regulation for the proliferation of breast cancer MCF-7 cells by the treatment with an extract of Glycyrrhiza glabra root.
Dong S; Inoue A; Zhu Y; Tanji M; Kiyama R
Food Chem Toxicol; 2007 Dec; 45(12):2470-8. PubMed ID: 17664038
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]